Tranexamic Acid (topical)
- Molecular Weight
- 157.21 g/mol
- Aliases
- TXA topical, Lysteda (oral), topical use off-label
Pharmacological Mechanism
Synthetic lysine analog — competitively inhibits plasminogen binding to lysine residues → blocks plasmin activation. Anti-fibrinolytic (approved in menorrhagia, trauma bleeding). Topical/oral melasma effect proposed via inhibition of plasmin-mediated keratinocyte-driven melanocyte stimulation.
Dosing Guidelines
- Transdermal (TD): Typical 333 mg (Range: 250–500 mg)
- Oral (PO): Typical 333 mg (Range: 250–500 mg)
Pathways It Modulates
Target Organ Systems